Switching from natalizumab to fingolimod

Ludwig Kappos(University Hospital of Basel), Athanasios P. Kyritsis, Mikko Kallela(Helsinki University Hospital), Andreas Link(Universitätsklinikum des Saarlandes), Andreas Steinbrecher, Gavin Giovannoni(Queen Mary University of London), Yvonne Naegelin(University Hospital of Basel), Veronika Tichá, Helmut Butzkueven(The Alfred Hospital), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Eva Meluzínová, Philipp von Rosenstiel(Biogen (United States)), Frank Dahlke(Ophthalmology Clinic), Heinz Wiendl(University Medical Center Freiburg), Johannes Boehringer, Gıancarlo Comı(Casa di Cura Columbus), Kerstin Hellwig(St. Josef-Hospital), Michael Lang(Deutsches Herzzentrum München), Davorka Tomic(Multiple Sclerosis Research Institute), Till Sprenger(University of Basel), Marta Vachová(Regional Museum in Teplice), Peter Emrich(Oxford Instruments (United Kingdom)), Ernst‐Wilhelm Radue, Nicole Mueller‐Lenke(Oxford Instruments (United Kingdom)), Klaus Gehring, Hans‐Peter Hartung(The University of Sydney), Antonios Tavernarakis, Gerd Reifschneider, Andreas Bitsch, Tobias Derfuß(University of Basel), Hans-Juergen von Giesen, Sarah Griffiths(Oxford Instruments (United Kingdom)), Erik Strauss(University of Maryland, Baltimore), Nikolaos Vlaikidis, Wilfried Lueer, Ying Zhang(Xihua University), Marinos C. Dalakas, Sylke Schlemilch-Paschen, Rebecca Gottschalk(Oxford Instruments (United Kingdom)), Eva-Maria Maida, Gerhard Roth, Joerg Osterhage, Thomas Brosch, Nikolaos Fakas, Eugen Schlegel, Arnfin Bergmann, Richard Macdonell
Neurology
May 30, 2015
Cited by 116


Related Papers